Key result
Nocturnal hypertension affects up to ~95% of kidney transplant recipients, driving graft loss and CV events.
Why the study?
Cardiovascular disease remains the leading cause of morbidity and mortality in kidney transplant recipients, among whom nocturnal hypertension and abnormal dipping patterns are observed in up to 95% and strongly drive adverse cardiovascular and graft outcomes.
What are the epidemiology, pathophysiology, prognostic significance for cardiovascular and graft outcomes, and management strategies for nocturnal hypertension and abnormal dipping patterns in kidney transplant recipients?
What are the epidemiology, pathophysiology, prognostic significance for cardiovascular and graft outcomes, and management strategies for nocturnal hypertension and abnormal dipping patterns in kidney transplant recipients?
Answers are grounded in this paper and cite their sources.
Nocturnal hypertension and abnormal dipping profiles affect up to 95% of kidney transplant recipients and strongly predict graft loss and cardiovascular events, warranting routine 24-hour ambulatory blood pressure monitoring beyond standard office readings.
Kidney transplantation markedly improves survival and quality of life in patients with kidney failure; however, cardiovascular disease remains the leading cause of morbidity and mortality among kidney transplant recipients (KTRs). Hypertension after kidney transplantation is very common and is strongly associated with adverse cardiovascular as well as graft-related outcomes. Notably, hypertension in this population exhibits distinct features, including exceptionally high rates of masked hypertension; this is largely driven by the frequent occurrence of elevated nocturnal BP and abnormal dipping patterns, which were observed in up to 95% of KTRs. Observational studies consistently demonstrate that higher nocturnal BP and abnormal dipping profiles are linked to accelerated graft function loss, cardiovascular events, and hypertension-mediated target-organ damage, frequently with stronger prognostic value than office or daytime BP measurements. In this review, we summarize the current evidence on circadian BP phenotypes and nocturnal hypertension in KTRs, focusing on epidemiology, underlying mechanisms, prognostic implications for cardiovascular and graft outcomes, and contemporary strategies for diagnosis and management.
No takes yet. Share an insight, caveat, or question.
Georgiou et al. (2026) conducted a review in Nocturnal hypertension and abnormal dipping patterns in kidney transplant recipients. Nocturnal hypertension and abnormal nighttime blood pressure dipping patterns vs. Normal circadian blood pressure dipping profile or normotension was evaluated on Prevalence of nocturnal hypertension and abnormal dipping patterns, and associations with graft and cardiovascular outcomes. Nocturnal hypertension and abnormal dipping patterns affect up to 95% of kidney transplant recipients and are strongly associated with accelerated graft function loss and cardiovascular events.
Synapse has enriched 10 related papers. Consider them for comparative context: